Just like your Spotify Wrapped, this is what you, dear readers, paid most attention to in the last 12 months.
Do you ever wonder what your colleagues are thinking about it? We can help! (At least when it comes to oncology-related topics. Not so much their hopes and dreams, existential angst, or what to make for dinner.)
These are the five most-read stories from Oncology Republic in 2022. If you’re stuck for conversation, why not use one of these as an icebreaker at the next awkward conference mixer or Auntie Mabel’s 90th?
1. Vaping has been a huge topic this year and it’s not restricted to clinical audiences, so it’s a safe bet you’ll find someone to chat to about this one, if you don’t mind a bit of controversy.
2. Local research is worth sharing and getting excited about. We got in touch to find out how it was going and you’ll be pleased to know that the research team has recently been awarded US$10m to develop next-generation theranostics.
3. There’s much about oncology that is outside the treatment room.
4. Equity is high on the list of priorities for the oncology community. This bodes well for making it happen.
5. If you haven’t yet got around to reading the full draft of the long-anticipated Australian Cancer Plan, here’s a neat summary.
We’ll be back in your inbox in February 2023. If there’s anything in particular you’d like us to cover, drop us a line (write to mariella@medicalrepublic.com.au) or leave a comment below.
Wishing you all the best for the start of a new year, and if there’s a break in your near future, we hope it’s a good one!
